CDK2 and breast cancer: It had been confirmed that GLK triterpenes both concentration- and time-dependently mediate G1 cell cycle arrest and significantly decrease the protein level of CDK2, CDK6, cycle D1, p-Rb and c-Myc in MCF-7 human breast cancer cells [26].